Lacosamide Oral Solution
- Product NDC
- 62135-885
- 11-digit product format
- 621350885
- Labeler code
- 62135
- Product ID
- 62135-885_2df7ee04-2970-8b37-e063-6294a90a29a4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lacosamide
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA215154
- Marketing category
- ANDA
- Marketing start
- 2024-05-15
- Substance
- LACOSAMIDE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 563KS2PQY5 | LACOSAMIDE | 175481-36-4 | LACOSAMIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-885-22 | 62135088522 | 200 mL in 1 BOTTLE (62135-885-22) | 200 ml | 2024-11-27 | No | No | Historical |
| 62135-885-23 | 62135088523 | 2 TRAY in 1 BOX (62135-885-23) / 10 CUP in 1 TRAY / 10 mL in 1 CUP (62135-885-10) | 2 tray | 2025-02-10 | No | No | Historical |
| 62135-885-24 | 62135088524 | 2 TRAY in 1 BOX (62135-885-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (62135-885-05) | 2 tray | 2025-02-10 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Lacosamide Oral Solution | Chartwell RX, LLC | 2025-02-12 | HUMAN PRESCRIPTION DRUG LABEL | 2 |